Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate

Ajith Cherian1, K P Divya2, Sarath Chandra Shetty3

  • 1Associate Professor, Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum , Kerala, PIN-695011, India.

Insights

This study reports the first case of coexisting Myelin oligodendrocyte glycoprotein (MOG) antibody, N-methyl-D-aspartate receptor (NMDAR) antibody, and Contactin-associated protein-like 2 (CASPR2) antibody encephalitis. Imaging findings may suggest this rare triple-antibody autoimmune encephalitis.

Area of Science:

  • Neuroimmunology
  • Neurology
  • Autoimmune Diseases

Background:

  • Myelin oligodendrocyte glycoprotein (MOG) antibody disease can present as focal encephalitis.
  • Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis frequently co-occurs with MOG antibodies due to receptor coexpression.
  • Contactin-associated protein-like 2 (CASPR2) antibodies are associated with central and peripheral nervous system disorders.

Discussion:

  • This report details a unique case of a young adult with neuropsychiatric, cognitive, and long tract symptoms.
  • The patient exhibited strong positivity for MOG, NMDAR, and CASPR2 antibodies simultaneously.
  • This presentation represents the first documented instance of coexistent antibodies against MOG, NMDAR, and CASPR2.

Key Insights:

  • Bilateral cingulate gyrus involvement with contrast enhancement may indicate coexistent MOG and NMDAR antibodies.
  • Bilateral hippocampal T2 hyperintensities are observed in both CASPR2 and anti-NMDAR encephalitis.
  • The patient's combination of cingulate and hippocampal lesions suggests a potential imaging signature for triple-antibody positivity.

Outlook:

  • Further research is needed to understand the clinical implications and diagnostic criteria for triple-antibody autoimmune encephalitis.
  • Investigating the pathogenic mechanisms underlying coexistent MOG, NMDAR, and CASPR2 antibody encephalitis is crucial.
  • Developing targeted therapeutic strategies for this rare autoimmune neurological condition is a future direction.

Related Concept Videos